RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 3 filers reported holding RELAY THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,040 | -85.4% | 2,264 | -78.2% | 0.00% | -75.0% |
| Q2 2023 | $130,147 | +175774.3% | 10,362 | +130.8% | 0.00% | +100.0% |
| Q1 2023 | $74 | -52.6% | 4,490 | -56.9% | 0.00% | -66.7% |
| Q4 2022 | $156 | -99.9% | 10,406 | +13.6% | 0.01% | +100.0% |
| Q3 2022 | $205,000 | -19.3% | 9,161 | -39.7% | 0.00% | -50.0% |
| Q2 2022 | $254,000 | +213.6% | 15,181 | +460.6% | 0.01% | +500.0% |
| Q1 2022 | $81,000 | -65.4% | 2,708 | -64.4% | 0.00% | -75.0% |
| Q4 2021 | $234,000 | -15.2% | 7,609 | -12.9% | 0.00% | -42.9% |
| Q3 2021 | $276,000 | +106.0% | 8,740 | +140.3% | 0.01% | +133.3% |
| Q2 2021 | $134,000 | +6.3% | 3,637 | -0.5% | 0.00% | +50.0% |
| Q1 2021 | $126,000 | -57.3% | 3,657 | -48.4% | 0.00% | -77.8% |
| Q4 2020 | $295,000 | +35.3% | 7,084 | +38.3% | 0.01% | +350.0% |
| Q3 2020 | $218,000 | – | 5,124 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,139,380 | $73,958,000 | 8.86% |
| Darwin Global Management, Ltd. | 782,471 | $27,050,000 | 5.30% |
| EcoR1 Capital, LLC | 3,429,363 | $118,553,000 | 5.26% |
| Foresite Capital Management V, LLC | 400,000 | $13,828,000 | 4.06% |
| Grace Capital | 183,112 | $6,330,000 | 4.03% |
| BVF INC/IL | 2,873,147 | $99,325,000 | 3.72% |
| Casdin Capital, LLC | 3,375,058 | $116,676,000 | 3.48% |
| Fernwood Investment Management, LLC | 185,063 | $6,398,000 | 2.35% |
| Alphabet Inc. | 1,568,486 | $54,222,000 | 2.19% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $964,675,000 | 1.67% |